Dr Abeer Shabaan

Queen Elizabeth Hospital Birmingham & University of Birmingham

Dr Shaaban is a specialist breast pathologist at Queen Elizabeth Hospital Birmingham and Honorary Senior Lecturer at the University of Birmingham. She is Breast Pathology Clinical Advisor for West Midlands, Member of Big 18 group, Lead of NCRI CM-PATH Workstream 2 (clinical trials) and member of the International Committee of the Royal College of Pathologists.

She completed her PhD in molecular pathology at the University of Liverpool, did her pathology training at the West Midlands and Yorkshire regions before working as consultant pathologist in Leeds then Birmingham. She has led and contributed to a number of breast research studies and breast cancer trials and
published over 100 papers in the field. Dr Shaaban was member of the NCRI breast CSG and chair of the Translational Subgroup of the NCRI Breast Clinical Studies Group.

dont miss

Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

The seminar will cover issues related to the multidisciplinary approach and pathological handling of neoadjuvant chemotherapy specimens, methods of histological assessment, importance of radiological correlation and recent developments including tumour bed biopsies.

EVEN MORE SEMINARS

  • Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg): Speaking at the Oncology Convention

    Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg)
    Sandwell and West Birmingham Hospitals NHS Trust

    Chest Wall Perforator Flaps for Partial Breast Reconstruction

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?

  • Lucinda Billingham: Speaking at the Oncology Convention

    Lucinda Billingham
    University of Birmingham - Cancer Research Clinical Trials Unit

    National Lung Matrix Trial: testing multiple novel targeted treatments

  • Dr Natalie Cook: Speaking at the Oncology Convention

    Dr Natalie Cook
    University of Manchester/Christie NHS Foundation Trust

    Early phase trial options in prostate cancer

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view